Clinical trials: Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Relapsed or Refractory (R/R) Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL)

A Compassionate Use (CU) Program of Odronextamab

• Available
• Age: All ages
• Expanded access

Provide compassionate use of odronextamab

Conditions

Relapsed or Refractory (R/R) Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Non-Hodgkin Lymphoma (NHL), High-Grade B-Cell Lymphoma (HGBCL)

Trial name

NCT05619367

Testing

Odronextamab

Sponsor

Regeneron Pharmaceuticals